Sodium and chloride disturbances in critically ill adult patients: A protocol for a sub‐study of the FLUID ‐ ICU cohort study
Acta Anaesthesiologica Scandinavica · 2025
DOI: 10.1111/aas.70028 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Acta Anaesthesiologica Scandinavica, 2025. Verfasst von Clara Molin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesia and Intensive Care, Copenhagen University Hospital - North Zealand, Hilleroed, Denmark. Hauptthemen laut MEDLINE: Critical Illness, Chlorides, Sodium, Water-Electrolyte Imbalance. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Gangstedfonden, Nordsjællands Hospital, Savvaerksejer Jeppe Juhl og Hustru Ovita Juhls Mindelegat.
Abstract (Originalsprache)
Background
Disturbances in plasma sodium and chloride are common in adults admitted to the intensive care unit (ICU) and may affect patient outcomes. Fluid administration practices in the ICU have changed in recent years with a trend toward using more restrictive fluid strategies. These changes may have influenced the patterns and proportions of electrolyte disturbances in ICU patients. Therefore, we aim to provide contemporary data on the frequency of hypernatremia, hyponatremia, hyperchloremia, and hypochloremia in adult ICU patients, assess risk factors, and association with clinical outcomes in an international cohort.
Methods
This is the protocol for a sub‐study of the FLUID‐ICU study (“Fluid administration and fluid accumulation in intensive care units—an international inception cohort study”). The FLUID‐ICU study is a prospective international 14‐day inception cohort study with a minimum sample size of 1000 patients from more than 50 ICUs. Patients are followed daily from ICU admission to discharge or death with a maximum of 28 days. A follow‐up is performed at Day 90 after ICU admission. The primary outcomes of this sub‐study are the proportion of patients with hypernatremia, hyponatremia, hyperchloremia, and hypochloremia. We will assess days alive without the use of life support at Day 90, and risk factors for developing disturbances in sodium and chloride including disease severity by SMS‐ICU score, type of ICU, use of diuretics, and presence of fluid accumulation. Furthermore, days alive and out of hospital and mortality at Day 90 will be reported descriptively.
Conclusion
In this study, we will provide important new epidemiological data on the burden of sodium and chloride disturbances in adult ICU patients internationally.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anaesthesia and Intensive Care, Copenhagen University Hospital - North Zealand, Hilleroed, Denmark.
- Department of Intensive Care 4131, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
- Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
ORCID-Profile: Clara Molin, Sine Wichmann
Förderung
- Gangstedfonden
- Nordsjællands Hospital
- Savvaerksejer Jeppe Juhl og Hustru Ovita Juhls Mindelegat
Zitieren
APA
Molin, C., Wichmann, S., Schønemann-Lund, M., Møller, M. H., & Bestle, M. H. (2025). Sodium and chloride disturbances in critically ill adult patients: A protocol for a sub‐study of the FLUID ‐ ICU cohort study. Acta Anaesthesiologica Scandinavica. https://doi.org/10.1111/aas.70028
Vancouver
Molin C, Wichmann S, Schønemann-Lund M, Møller MH, Bestle MH. Sodium and chloride disturbances in critically ill adult patients: A protocol for a sub‐study of the FLUID ‐ ICU cohort study. Acta Anaesthesiologica Scandinavica. 2025. doi:10.1111/aas.70028
BibTeX
@article{Molin2025,
author = {Molin, Clara and Wichmann, Sine and Schønemann-Lund, Martin and Møller, Morten H and Bestle, Morten H},
title = {Sodium and chloride disturbances in critically ill adult patients: A protocol for a sub‐study of the FLUID ‐ ICU cohort study},
journal = {Acta Anaesthesiologica Scandinavica},
year = {2025},
doi = {10.1111/aas.70028}
}
EUVIMED